U.S. market Closed. Opens in 7 hours 37 minutes

RXST | RxSight, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue89.08M49.01M22.59M14.68M2.24M
Cost of Revenue35.31M27.68M18.08M12.97M4.06M
Gross Profit53.77M21.33M4.52M1.71M-1.82M
Operating Expenses103.85M84.65M57.30M37.11M44.77M
Selling, General & Admin74.80M58.66M32.80M15.18M15.20M
Research & Development29.05M25.98M24.50M21.93M29.57M
Other Operating Expenses-103.00KN/AN/AN/AN/A
Operating Income-50.09M-63.32M-52.79M-35.41M-46.07M
Other Expenses / Income1.50M-3.43M4.11M63.04M172.31M
Before Tax Income-48.59M-66.75M-48.68M27.63M126.24M
Income Tax Expenses20.00K9.00K8.00K57.00K24.00K
Net Income-48.61M-66.76M-48.69M27.57M126.22M
Interest Expenses3.31M4.95M3.68M510.00K26.00K
Basic Shares Outstanding34.46M27.66M27.37M27.62M27.62M
Diluted Shares Outstanding34.46M27.66M27.37M27.62M27.62M
EBITDA-45.84M-61.80M-52.73M-30.85M-40.35M
EBITDA Margin-51.46%-126.11%-233.40%-210.18%-1,800.71%
EBIT-45.28M-61.80M-45.00M28.14M126.27M
EBIT Margin-50.83%-126.11%-199.17%191.73%5,634.54%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙